Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference

February 16, 2011

MISSISSAUGA, Ontario, Feb. 16, 2011 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the RBC Capital Markets' 2011 Healthcare Conference on Thursday, March 3, 2011, at 11:00 a.m. ET. The conference will be held at the New York Palace Hotel in New York City, NY.

A live webcast and audio archive of the presentation will be available on the company's website at http://www.valeant.com/. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at http://www.valeant.com/.

Contact Information:

Laurie W. Little

949-461-6002

laurie.little@valeant.com

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All